Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration

Leukemia Research

Volumn 27, Issue 3, 2003, Pages 215-220

  Wadhwa, Punit D ^a   Lazarus, Hillard M ^a   Koc, Omer N ^a   Jaroscak, Jennifer ^b   Woo, David ^c   Stevens, Cladd E ^d   Rubinstein, Pablo ^d   Laughlin, Mary J ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c AMGEN INC   (United States)

^d NEW YORK BLOOD CENTER   (United States)

Author keywords

Hematopoiesis; Stem cell factor; Umbilical cord blood

Indexed keywords

HLA ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT METHIONYL HUMAN STEM CELL FACTOR; RECOMBINANT STEM CELL FACTOR; UNCLASSIFIED DRUG;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD DONOR; CANCER REGRESSION; CASE REPORT; CELL COUNT; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONVALESCENCE; CYTOGENETICS; FOLLOW UP; HEMATOPOIETIC SYSTEM; HLA MATCHING; HUMAN; INFUSION; MALE; NEUTROPHIL; PRIORITY JOURNAL; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADULT; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG THERAPY, COMBINATION; FILGRASTIM; GRAFT SURVIVAL; HEMATOPOIESIS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; STEM CELL FACTOR; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0037355105     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00090-5     Document Type: Article

References (28)

1. Rubinstein P., Carrier C., Scaradavou A.et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New Engl. J. Med. 339:1998;1565-1577.
2. Gluckman E., Rocha V., Boyer-Chammard A.et al. Outcome of cord-blood transplantation from related and unrelated donors. New Engl. J. Med. 337:1997;373-381.
3. Kurtzberg J., Laughlin M., Graham M.et al. Placental blood as a source of hematopoetic stem cells for transplantation into unrelated recipients. New Engl. J. Med. 335:1996;155-166.
4. Wagner J., Rosenthal J., Sweetman R.et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 88:1996;795-802.
5. Laughlin M.J., Barker J., Bambach B.et al. Hematopoietic engraftment and survival after unrelated donor umbilical cord-blood transplantation in adult recipients. New Engl. J. Med. 344:2001;1815-1822.
6. McNiece I., Kubegov D., Kerzic P.et al. Increased expansion and differentiation of cord-blood products using a two-step expansion culture. Exp. Hematol. 28:2000;1181-1186.
7. Koller M.R., Manchel I., Maher R.J.et al. Clinical-scale human umbilical cord-blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant. 21:1998;653-663.
8. Pecora A.L., Stiff P., Jennis A.et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogeneous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant. 25:2000;797-799.
9. Stiff P., Pecora A., Parthasarthy M.et al. Umbilical cord-blood transplants in adults using a combination of unexpanded and ex vivo expanded cells: preliminary clinical observations. Blood. 92:1998;646a.
10. Barker J., McGlave P., Weisdorf D.et al. Creation of a double chimera by transplantation of two unrelated donor umbilical cord-blood units. Blood. 96:2000;207a.
11. Brandt J., Briddell R.A., Srour E.F.et al. Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood. 79:1992;634-641.
12. Duarte R.F., Frank D.A. SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways. Blood. 96:2000;3422-3430.
13. Rubinstein P., Dobrila L., Rosenfield R.E.et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc. Natl. Acad. Sci. U.S.A. 92:1995;10119-10122.
14. Dewald G., Stallard R., Al Saadi A.et al. A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes. Am. J. Med. Genet. 67:1998;216-318.
15. Sullivan B.A., Jenkins L.S., Karson E.M.et al. Evidence for structural heterogeneity from molecular cytogenetic analysis of dicentric Robertsonian translocations. Am. J. Hum. Genet. 59:1996;167-175.
16. Przepiorka D., Weisdorf D., Martin P.et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 13:1994;389-396.
17. Flowers M., Kansu E., Sullivan K. Pathophysiology and treatment of graft-versus-host disease. Hematol. Oncol. Clin. North Am. 13:1999;1091-1112.
18. Laughlin M.J. Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplant. 27:2001;1-6.
19. Andrews R.G., Knitter G.H., Bartelmez S.H.et al. Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood. 78:1991;1975-1980.
20. Avraham H., Vannier E., Cowley S.et al. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood. 79:1992;365-371.
21. Andrews R.G., Bensinger W.I., Knitter G.H.et al. The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood. 80:1992;2715-2720.
22. Andrews R.G., Briddell R.A., Knitter G.H.et al. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells. Blood. 84:1994;800-810.
23. Crawford J., Lau D., Erwin R.et al. A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced non-small cell lung carcinoma (NSCLC). Proc. Ann. Meet. Am. Soc. Clin. Oncol. 12:1993;338a.
24. Kurtzberg J., Meyers F., Mcguire B., Crawford J. Mobilization of peripheral blood progenitor cells in patients given recombinant methionyl human stem cell factor. Proc. Ann. Meet. Am. Assoc. Cancer Res. 34:1993;1257a.
25. Moskowitz C.H., Stiff P., Gordon M.S.et al. Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients: results of a phase I/II trial. Blood. 89:1997;3136-3147.
26. Facon T., Harousseau J.L., Maloisel F.et al. Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial. Blood. 94:1999;1218-1225.
27. Kurtzberg J., Jaroscak J., Martin P.L.et al. Augmentation of umbilical cord-blood (UCB) transplantation with ex vivo expanded cells: a phase I trial using the replicell system. Blood. 94:1999;571a.
28. Shpall E., Quinones R., Giller R.et al. Transplantation of adult and paediatric cancer patients with cord-blood progenitors expanded ex vivo. Blood. 96:2000;206a.